David M. Koelle, MD

Professor
University of Washington

Disclosure(s): Curevo Vaccines: Advisor/Consultant; MaxHealth LLC: Advisor/Consultant; Oxford Immunotec: gift of reagents; Sanofi: Grant/Research Support; Sensei: Grant/Research Support

Poster(s):

• 1948 - Evaluation of a heterologous booster vaccine regimen: Pfizer-BioNTech BNT162b2 mRNA booster vaccine following priming with Novavax NVX-CoV2373
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET